Skip to content

Behavioural Brain Research

ISSN 1872-7549, 0166-4328

130 papers in the library · 1,076 citations · publishing 1994-2026

Papers

Sort Most recent Most cited

Phencyclidine increased while isolation rearing did not affect progressive ratio responding in rats: Investigating potential models of amotivation in schizophrenia.

Behavioural Brain Research May 17, 2019 Nurith Amitai, Susan B Powell, Jared W Young

Schizophrenia is a debilitating neurodevelopmental disorder affecting 1% of the global population with heterogeneous symptoms including positive, negative, and cognitive. While treatment for positive symptoms exists, none have been developed to treat negative symptoms. Animal models of schizophrenia are required to test targeted treatments and since patients exhibit reduced effort (breakpoints)...

Ketamine improved depressive‐like behaviors via hippocampal glucocorticoid receptor in chronic stress induced‐ susceptible mice

Behavioural Brain Research May 1, 2019 Wei Wang, Le Liu, Xiu Yang et al.

HighlightsSusceptible mice showed depressive‐like behaviors upon chronic social defeat stress.Plasma corticosterone concentration might predict susceptibility to chronic stress.Abnormal glucocorticoid receptor expression was associated with susceptibility.Ketamine exerted antidepressant effect via normalizing HPA axis response. &NA; Chronic stress is an important factor for depression. Most...

5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.

Behavioural Brain Research February 1, 2019 Arvie Abiero, Chrislean Jun Botanas, Leandro Val Sayson et al. 17 citations

5-Methoxy-α-methyltryptamine (5-MeO-AMT) is a tryptamine derivative that is used recreationally because of its reported hallucinogenic and mood elevating effects. Studies suggest that the psychopharmacological effects of tryptamines involve serotonin receptor 2a (5-HTR2a) activation in the brain. The head-twitch response (HTR) is widely used as a behavioral correlate for assessing 5-HTR2a...

DOI: 10.1016/j.bbr.2018.07.020 (opens in new tab) Full text (opens in new tab) 5-methoxy-a-methyltryptamine Conditioned place preference Head-twitch response Self-administration +1

Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish.

Behavioural Brain Research February 1, 2019 Andrey D. Volgin, Oleg A. Yakovlev, Konstantin A. Demin et al.

Atropine and scopolamine are classical muscarinic cholinergic antagonists that exert multiple CNS effects. Belonging to a group of deliriant hallucinogens, these drugs induce delirium-like hallucinations, hyperactivity, altered affective states and amnesia. However, as deliriants remain the least studied group of hallucinogens, their complex and poorly understood profiles necessitate further...

Neuronal glutamatergic changes and peripheral markers of cytoskeleton dynamics change synchronically 24 h after sub-anaesthetic dose of ketamine in healthy subjects.

Behavioural Brain Research February 1, 2019 Lejla Colic, Conor McDonnell, Meng Li et al.

Ketamine acts as a rapid-acting antidepressant by restoring glutamatergic deficits and activating synaptic plasticity processes, with peak activity 24 h after infusion. Microtubule dynamics are known to play a key role in modulation of cytoskeleton and synaptic plasticity, as well as in signalling events in peripheral blood cells. Here, we correlated ketamine-induced change in...

Episodic-like memory impairment induced by sub-anaesthetic doses of ketamine.

Behavioural Brain Research February 1, 2019 Ingrid Brasilino Montenegro Bento De Souza, Ywlliane da Silva Rodrigues Meurer, Priscila Macedo Tavares et al.

Episodic-like memory refers to integration of where and when a certain event (what) happened. The glutamatergic neurotransmission, particularly AMPA and NMDA receptors, in the dorsal hippocampus mediates episodic recall. Ketamine is a non-competitive NMDA antagonist with effect on cognitive performance and plasticity. The goal of this study was to evaluate the acute action of ketamine on...

Brief, daily meditation enhances attention, memory, mood, and emotional regulation in non-experienced meditators.

Behavioural Brain Research January 1, 2019 Julia C. Basso, Alexandra McHale, Victoria Ende et al.

Meditation is an ancient practice that cultivates a calm yet focused mind; however, little is known about how short, practical meditation practices affect cognitive functioning in meditation-naïve populations. To address this question, we randomized subjects (ages of 18-45) who were non-experienced meditators into either a 13-min daily guided meditation session or a 13-min daily podcast...

Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction.

Behavioural Brain Research September 17, 2018 Lakshmi Rajagopal, D Soni, Herbert Y. Meltzer

Pregnenolone sulfate (PregS), an endogenous neurosteroid, which negatively and positively modulates gamma amino butyric acid subunit A (GABAA) and N-methyl D-aspartate (NMDA) receptors (R) respectively, among other potential neuroplastic changes on synaptic processes, has shown some beneficial effects on treating cognitive impairment associated with schizophrenia (CIAS) and negative symptoms....

Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice.

Behavioural Brain Research July 16, 2018 María P García-Pardo, José Miñarro, María A. Aguilar

Currently, there is not an effective treatment for 3,4-methylenedioxymethamphetamine (MDMA) dependence but pharmacotherapies targeting glutamate neurotransmission are a promising strategy. Previously, we showed that blockade of glutamate NMDA and AMPA receptors impairs the conditioned rewarding effects of MDMA and cocaine, respectively. In this study we evaluated the role of AMPA receptors in...

DOI: 10.1016/j.bbr.2018.03.010 (opens in new tab) Full text (opens in new tab) MDMA Ampa receptors Cnqx Conditioned place preference +2

Male rats treated with subchronic PCP show intact olfaction and enhanced interest for a social odour in the olfactory habituation/dishabituation test

Behavioural Brain Research June 1, 2018 Emilia Tarland, J. Brosda

HighlightsSubchronic PCP treatment did not interfere with olfactory function in male rats.Olfactory exploratory motivation was unaltered by subchronic PCP.Male rats treated with subchronic PCP spent more time investigating a novel social odour. ABSTRACT The olfactory system participates in many sensory processes, and olfactory endophenotypes appear in a variety of neurological disorders such as...

Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats.

Behavioural Brain Research April 16, 2018 Nichole M Neugebauer, Masanori Miyauchi, Tatsuya Sato et al.

Abnormalities in prefrontal cortical and hippocampal GABAergic function are postulated to be major causes of the cognitive impairment associated with schizophrenia (CIAS). There are conflicting views on whether diminished or enhanced GABAergic activity contributes to the deficit in short-term novel object recognition (NOR) in the sub-chronic phencyclidine (scPCP) rodent model of CIAS. This...

DOI: 10.1016/j.bbr.2017.12.033 (opens in new tab) Full text (opens in new tab) Gaba Hippocampus Novel object recognition Phencyclidine +2

Downregulation of 5-hydroxytryptamine7 receptor in the medial prefrontal cortex ameliorates impulsive actions in animal models of schizophrenia.

Behavioural Brain Research April 2, 2018 Wei Zhang, Junhui Liu, Jinteng Feng et al.

R mRNA in the mPFC was significantly decreased to 5-Hydroxytryptamine7 (5-HT7) receptors in the medial prefrontal cortex (mPFC) play a critical role in complex cognitive impairment in schizophrenia. The mouse model of schizophrenia was established through the neonatal administration of phencyclidine (nPCP). Recombinant adeno-associated virus-mediated gene knockdown was used to investigate the...

DOI: 10.1016/j.bbr.2017.12.023 (opens in new tab) Full text (opens in new tab) Impulsivity Medial prefrontal cortex Phencyclidine Schizophrenia

Mindfulness and dynamic functional neural connectivity in children and adolescents.

Behavioural Brain Research January 15, 2018 Hilary A Marusak, Farrah Elrahal, Craig A Peters et al.

Interventions that promote mindfulness consistently show salutary effects on cognition and emotional wellbeing in adults, and more recently, in children and adolescents. However, we lack understanding of the neurobiological mechanisms underlying mindfulness in youth that should allow for more judicious application of these interventions in clinical and educational settings. Using multi-echo...

Anxiolytic-like effects of noribogaine in zebrafish.

Behavioural Brain Research July 14, 2017 Allan V. Kalueff, Aleksandra Kaluyeva, Émeline L. Maillet 21 citations

Noribogaine is the main psychoactive metabolite of the hallucinogenic drug ibogaine, and is a particularly interesting compound potentially useful to treat dependence and various psychiatric disorders. Here, we report the effects of noribogaine on anxiety and locomotion in zebrafish (Danio rerio), a new promising model organism in neurobehavioral and psychopharmacological research. Adult...

DOI: 10.1016/j.bbr.2017.05.008 (opens in new tab) Full text (opens in new tab) Noribogaine Anxiety management Zebrafish research Drug abuse treatment

Role of nitric oxide pathway in the conditioned rewarding effects of MDMA in mice.

Behavioural Brain Research May 4, 2017 María P García-Pardo, Marta Rodríguez‐arias, José Miñarro et al.

It is estimated that 2.1 million young adults used MDMA/Ecstasy in the last year in Europe. Vulnerable subjects can develop dependence after MDMA abuse but currently there does not exist an effective treatment for this disorder. The nitric oxide (NO) pathway seems to have an important role on the rewarding effects of different drugs and has been proposed as a new pharmacological treatment for...

DOI: 10.1016/j.bbr.2017.05.010 (opens in new tab) Full text (opens in new tab) MDMA Animals Mice N-methyl-3,4-methylenedioxyamphetamine +10

Cannabis exacerbates depressive symptoms in rat model induced by reserpine.

Behavioural Brain Research May 1, 2017 Yasser A Khadrawy, Hussein G Sawie, Omar M E Abdel-Salam et al.

Cannabis sativa is one of the most widely recreational drugs and its use is more prevalent among depressed patients. Some studies reported that Cannabis has antidepressant effects while others showed increased depressive symptoms in Cannabis users. Therefore, the present study aims to investigate the effect of Cannabis extract on the depressive-like rats. Twenty four rats were divided into:...

The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.

Behavioural Brain Research May 1, 2017 Akihiro Mouri, Yukihiro Noda, Minae Niwa et al.

3,4-Methylenedioxymethamphetamine (MDMA) is known to induce dependence and psychosis in humans. Brain-derived neurotrophic factor (BDNF) is involved in the synaptic plasticity and neurotrophy in midbrain dopaminergic neurons. This study aimed to investigate the role of BDNF in MDMA-induced dependence and psychosis. A single dose of MDMA (10mg/kg) induced BDNF mRNA expression in the prefrontal...

The brain and the subjective experience of time. A voxel based symptom-lesion mapping study.

Behavioural Brain Research April 21, 2017 Luigi Trojano, Michelina Caccavale, Francesco De Bellis et al.

The aim of the study was to identify the anatomical bases involved in the subjective experience of time, by means of a voxel based symptom-lesion mapping (VLSM) study on patients with focal brain damage. Thirty-three patients (nineteen with right-hemisphere lesions -RBD, and fourteen with left lesion- LBD) and twenty-eight non-neurological controls (NNC) underwent the semi-structured...

DOI: 10.1016/j.bbr.2017.04.031 (opens in new tab) Full text (opens in new tab) Humans Brain ischemia Intracranial hemorrhages Tomography, x-ray computed +15

Sex differences in psychotomimetic-induced behaviours in rats.

Behavioural Brain Research March 30, 2017 Andrea Gogos, Snezana Kusljic, Shane J Thwaites et al.

Animal model studies using equal numbers of males and females are sparse in psychiatry research. Given the marked sex differences observed in psychiatric disorders, such as schizophrenia, using both males and females in research studies is an important requirement. Thus the aim of this study was to examine sex differences in psychotomimetic-induced behavioural deficits relevant to psychosis. We...

DOI: 10.1016/j.bbr.2017.01.028 (opens in new tab) Full text (opens in new tab) Amphetamine Female Locomotor hyperactivity Phencyclidine +1

Cognitive and behavioural effects induced by social stress plus MDMA administration in mice.

Behavioural Brain Research February 15, 2017 María P García-Pardo, Concepción Roger-Sánchez, Marta Rodríguez‐arias et al.

Adverse life experiences such as social stress may make an individual more vulnerable to drug addiction and mental disorders associated with drug consumption. The present work aimed to evaluate the effects of stress induced by acute social defeat combined with the administration of 3,4-methylenedioxymethamphetamine (MDMA) on depression-like behaviour, memory function and motor response to drug...

DOI: 10.1016/j.bbr.2016.11.012 (opens in new tab) Full text (opens in new tab) Drug dependence Motor activity Object recognition Passive avoidance +2

Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish.

Behavioural Brain Research November 1, 2016 Luisa Ponzoni, Mariaelvina Sala, Daniela Braida

Little is known about the pharmacological effects of amphetamine derivatives. In the present study, the effect on social preference and anxiety-like behavior of 2,5-dimetoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA), in comparison with 3,4 methylenedioxymethamphetamine (MDMA) was investigated in zebrafish, an emerging model to study emotional behavior in an...

DOI: 10.1016/j.bbr.2016.08.009 (opens in new tab) Full text (opens in new tab) Hallucinogens Liokght-dark Novel tank Social preference +1

Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice.

Behavioural Brain Research October 1, 2016 Connor Thelen, Jonathon Sens, Joseph Mauch et al.

One of the most striking discoveries in the treatment of major depression was the finding that infusion of a single sub-anesthetic dose of ketamine induces rapid and sustained antidepressant effects in treatment-resistant depressed patients. However, ketamine's antidepressant-like actions are transient and can only be sustained by repeated drug treatment. Despite the fact that women experience...

Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model.

Behavioural Brain Research October 1, 2016 Ceren Sahin, Nazanin Doostdar, Joanna C. Neill

Negative symptoms in schizophrenia remain an unmet clinical need. There is no licensed treatment specifically for this debilitating aspect of the disorder and effect sizes of new therapies are too small to make an impact on quality of life and function. Negative symptoms are multifactorial but often considered in terms of two domains, expressive deficit incorporating blunted affect and poverty...

DOI: 10.1016/j.bbr.2016.06.021 (opens in new tab) Full text (opens in new tab) Animal model Nmda receptor Negative symptoms Pcp +1

Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm.

Behavioural Brain Research July 1, 2016 Mengjiao Zhang, Ming Li

Fear-potentiated startle (FPS) and prepulse inhibition (PPI) of acoustic startle are two widely used paradigms specifically designed to capture the impact of negative emotion (e.g. fear) and preattentive function on startle response. Currently, there is no single paradigm that incorporates both FPS and PPI, making it impossible to examine the potential interactions between fear and attention in...

DOI: 10.1016/j.bbr.2016.04.006 (opens in new tab) Full text (opens in new tab) Diazepam Fear-potentiated startle Phencyclidine Rat

GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.

Behavioural Brain Research February 15, 2016 Lakshmi Rajagopal, Jeffrey S Burgdorf, Joseph R Moskal et al.

GLYX-13 (rapastinel), a tetrapeptide (Thr-Pro-Pro-Thr-amide), has been reported to have fast acting antidepressant properties in man based upon its N-methyl-D-aspartate receptor (NMDAR) glycine site functional partial agonism. Ketamine, a non-competitive NMDAR antagonist, also reported to have fast acting antidepressant properties, produces cognitive impairment in rodents and man, whereas...